As per recent reports, it has been unveiled that yen has declined to its weakest in four months when compared with dollar.
The yen has declined by 0.8% to 100.79 per dollar. Experts were of the view that the decline is the biggest one since July 19. When compared to euro, the yen was found to have declined by 0.5% to 135.09 per euro.
On the other hand, Japan has been making every possible effort in order to get things in control. In a recently held meeting, the Bank of Japan has announced to fulfill its commitment of expanding its monetary base.
It has been found that Japan's central bank has made an expansion of as much as 70 trillion yen a year. After knowing the same, many economists are of the belief that Japan is going to add stimulus in the second quarter of 2014.
Greg Gibbs, a currency strategist at Royal Bank of Scotland Group Plc in Singapore, was of the view about BOJ officials, "still sticking to their guns on their inflation target and they're prepared to do more if required".
In addition, Japan has said to be the worst performer in the list of 10 developed-nation currencies by the Bloomberg Correlation-Weighted Indexes. They have made their decision on the basis of yen performance.
In its annual Environmental Responsibility Report for fiscal year 2015 released last Thursday, tech giant Apple has revealed that nearly 90 million pounds of unwanted or broken electronics were processed by the company over the last one year....
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
There was a time just a few years back when Spain ranked second after Greece, as a figure of the euro zone's huge debt crisis and economic slowdown. The country's unemployment climbed to a huge twenty seven percent and the economy was still...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
On Tuesday, tech giant Google released latest to show how much of its online traffic is...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
There are a lot of things not going right at the IRS and...
On Thursday, the US Federal Bureau of Investigation (FBI...
In an announcement made via a blog post on Thursday,...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).